Literature DB >> 23717745

Predictors of malignancy in chronic calcific pancreatitis with head mass.

Senthilkumar Perumal1, Ravichandran Palaniappan, Sastha Ahanatha Pillai, Vimalraj Velayutham, Jeswanth Sathyanesan.   

Abstract

AIM: To prospectively analyse the clinical, biochemical and radiological characteristics of the mass lesions arising in a background of chronic calcific pancreatitis (CCP).
METHODS: Eighty three patients, who presented with chronic pancreatitis (CP) and a mass lesion in the head of pancreas between February 2005 and December 2011, were included in the study. Patients who were identified to have malignancy underwent Whipple's procedure and patients whose investigations were suggestive of a benign lesion underwent Frey's procedure. Student t-test was used to compare the mean values of imaging findings [common bile duct (CBD), main pancreatic duct (MPD) size] and laboratory data [Serum bilirubin, carbohydrate antigen 19-9 (CA 19-9)] between the groups. Receiver operating characteristic curve (ROC curve) analysis was done to calculate the cutoff valves of serum bilirubin, CA 19-9, MPD and CBD size. The sensitivity, specificity, positive predictive valve (PPV) and negative predictive value (NPV) were calculated using these cut off points. Multivariate analysis was performed using logistic regression model.
RESULTS: The study included 56 men (67.5%) and 27 women (32.5%). Sixty (72.3%) patients had tropical calcific pancreatitis and 23 (27.7%) had alcohol related CCP. Histologically, it was confirmed that 55 (66.3%) of the 83 patients had an inflammatory head mass and 28 (33.7%) had a malignant head mass. The mean age of individuals with benign inflammatory mass and those with malignant mass was 38.4 years and 45 years respectively. Significant clinical features that predicted a malignant head mass in CP were presence of a head mass in CCP of tropics, old age, jaundice, sudden worsening abdominal pain, gastric outlet obstruction and significant weight loss (P ≤ 0.05). The ROC curve analysis showed a cut off value of 5.8 mg/dL for serum bilirubin, 127 U/mL for CA 19-9, 11.5 mm for MPD size and 14.5 mm for CBD size.
CONCLUSION: Elevated Serum bilirubin and CA 19-9, and dilated MPD and CBD were useful in predicting malignancy in patients with CCP and head mass.

Entities:  

Keywords:  Carcinoma head of pancreas; Chronic calcific pancreatitis; Pancreatic head mass; Risk factors of malignancy

Year:  2013        PMID: 23717745      PMCID: PMC3664296          DOI: 10.4240/wjgs.v5.i4.97

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  35 in total

1.  Specificity of elevated CA 19-9 levels in chronic pancreatitis.

Authors:  A Minghini; L J Weireter; R R Perry
Journal:  Surgery       Date:  1998-07       Impact factor: 3.982

Review 2.  Observations and surgical management of tropical pancreatitis in Kerala and southern India.

Authors:  P G Thomas; P Augustine; H Ramesh; N Rangabashyam
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

3.  Duodenum-preserving pancreatic head resection leads to relief of common bile duct stenosis.

Authors:  Wolfgang Schlosser; Bertram Poch; Hans G Beger
Journal:  Am J Surg       Date:  2002-01       Impact factor: 2.565

Review 4.  Alcoholic pancreatopathy: a proposed new diagnostic category representing the preclinical stage of alcoholic pancreatic injury.

Authors:  Naohiro Sata; Masaru Koizumi; Hideo Nagai
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 5.  Tropical chronic pancreatitis: an update.

Authors:  V Mohan; G Premalatha; C S Pitchumoni
Journal:  J Clin Gastroenterol       Date:  2003-04       Impact factor: 3.062

6.  Pancreatitis and the risk of pancreatic cancer.

Authors:  E Fernandez; C La Vecchia; M Porta; E Negri; B d'Avanzo; P Boyle
Journal:  Pancreas       Date:  1995-08       Impact factor: 3.327

Review 7.  Tropical chronic pancreatitis.

Authors:  K K Barman; G Premalatha; V Mohan
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

8.  Factors affecting outcome after Frey procedure for chronic pancreatitis.

Authors:  Anbalagan Amudhan; Tirupporur Govindaswamy Balachandar; Devy Gounder Kannan; Govindhasamy Rajarathinam; Vellayudham Vimalraj; Shanmugasundaram Rajendran; Palanisamy Ravichandran; Satyanesan Jeswanth; Rajagopal Surendran
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Duodenum-preserving resection of the head of the pancreas in severe chronic pancreatitis. Early and late results.

Authors:  H G Beger; M Büchler; R R Bittner; W Oettinger; R Roscher
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

10.  Description and rationale of a new operation for chronic pancreatitis.

Authors:  C F Frey; G J Smith
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

View more
  10 in total

1.  Pancreatic cancer in chronic pancreatitis.

Authors:  Puneet Dhar; S Kalghatgi; Vivek Saraf
Journal:  Indian J Surg Oncol       Date:  2015-01-21

Review 2.  Head mass in chronic pancreatitis: Inflammatory or malignant.

Authors:  Amit K Dutta; Ashok Chacko
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

Review 3.  Chronic Pancreatitis: A Review.

Authors:  A K Pujahari
Journal:  Indian J Surg       Date:  2015-05-14       Impact factor: 0.656

4.  Preoperative Platelet-Lymphocyte Ratio Augments CA 19-9 as a Predictor of Malignancy in Chronic Calcific Pancreatitis.

Authors:  Ashwin Rammohan; Sathya D Cherukuri; Ravichandran Palaniappan; Senthil Kumar Perumal; Jeswanth Sathyanesan; Manoharan Govindan
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

5.  Clinical profile of PanIN lesions in tropical chronic pancreatitis.

Authors:  R S Sindhu; G Parvathy; K Fysal; M K Jacob; S Geetha; B Krishna; Bonny Natesh; Ramesh Rajan
Journal:  Indian J Gastroenterol       Date:  2015-11-20

Review 6.  Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.

Authors:  Robert Słotwiński; Sylwia Małgorzata Słotwińska
Journal:  Cent Eur J Immunol       Date:  2017-01-24       Impact factor: 2.085

7.  Multi-modality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head.

Authors:  Zhibing Ruan; Jun Jiao; Dingyu Min; Jinhuan Qu; Jing Li; Jing Chen; Qi Li; Chunhong Wang
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

8.  mutTCPdb: a comprehensive database for genomic variants of a tropical country neglected disease-tropical calcific pancreatitis.

Authors:  Garima Singh; Basharat Bhat; M S K Jayadev; Ch Madhusudhan; Ashutosh Singh
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

9.  Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass.

Authors:  Bishnupriya Chhatriya; Moumita Mukherjee; Sukanta Ray; Barsha Saha; Somdatta Lahiri; Sandip Halder; Indranil Ghosh; Sujan Khamrui; Kshaunish Das; Samsiddhi Bhattacharjee; Saroj Kant Mohapatra; Srikanta Goswami
Journal:  J Transl Med       Date:  2020-11-07       Impact factor: 5.531

Review 10.  [Chronic pancreatitis : Characterization and differentiation from pancreatic cancer].

Authors:  Antonia Kristic; N Bastati; S Poetter-Lang; A Messner; A Herold; D Tamandl; Ahmed Ba-Ssalamah
Journal:  Radiologe       Date:  2021-05-17       Impact factor: 0.635

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.